Real-World Outcomes and Prognostic Factors in Patients Receiving Nivolumab Therapy for Recurrent or Metastatic Head and Neck Carcinoma
暂无分享,去创建一个
K. Omori | R. Asato | H. Harada | I. Tateya | R. Hori | Tsuyoshi Kojima | S. Shinohara | Morimasa Kitamura | H. Tamaki | Yoshiharu Kitani | Y. Kumabe | K. Ichimaru | K. Honda | Hiroki Kagoshima | T. Tsujimura